ProPublica looks at the Rx-$ nexus

Share this article:

Non-profit journo outfit ProPublica found that at least 17 of the top 20 prescribers of beta blocker Bystolic in Medicare's prescription drug program in 2010 had also been paid by Forest for promotional talks.

Nine of the top 10 prescribers of Alzheimer's drug Exelon received money from Novartis, and eight of the top 10 for J&J painkiller Nucynta were paid speakers, as were six of the top 10 for Pfizer antidepressant Pristiq.

The data used came from the Dollars for Docs tool, which includes payments from 15 drug makers, as well as its new ­Prescriber Checkup, which has data on prescribing in Medicare Part D.
Share this article:

Email Newsletters

More in Features

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...

Read the complete August 2014 Digital Edition

Read the complete August 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.